14,939 Shares in Align Technology, Inc. (NASDAQ:ALGN) Acquired by Virtu Financial LLC

Virtu Financial LLC bought a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 14,939 shares of the medical equipment provider's stock, valued at approximately $3,115,000.

A number of other institutional investors also recently bought and sold shares of ALGN. Picton Mahoney Asset Management grew its stake in Align Technology by 69.9% in the fourth quarter. Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 58 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of Align Technology by 9.1% in the 4th quarter. Smartleaf Asset Management LLC now owns 766 shares of the medical equipment provider's stock worth $158,000 after buying an additional 64 shares during the period. Beech Hill Advisors Inc. increased its stake in shares of Align Technology by 0.6% during the fourth quarter. Beech Hill Advisors Inc. now owns 11,632 shares of the medical equipment provider's stock valued at $2,425,000 after buying an additional 65 shares during the period. New York Life Investment Management LLC raised its holdings in shares of Align Technology by 0.7% in the fourth quarter. New York Life Investment Management LLC now owns 9,406 shares of the medical equipment provider's stock valued at $1,961,000 after acquiring an additional 68 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in Align Technology by 1.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,799 shares of the medical equipment provider's stock worth $1,626,000 after acquiring an additional 91 shares during the period. 88.43% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

ALGN has been the subject of several recent research reports. Leerink Partners upgraded shares of Align Technology from a "market perform" rating to an "outperform" rating and boosted their price target for the company from $235.00 to $280.00 in a report on Monday, January 6th. Mizuho lowered their target price on shares of Align Technology from $295.00 to $250.00 and set an "outperform" rating for the company in a research note on Tuesday. Wells Fargo & Company started coverage on Align Technology in a report on Friday, February 14th. They set an "overweight" rating and a $255.00 price objective for the company. Evercore ISI boosted their target price on Align Technology from $240.00 to $260.00 and gave the stock an "outperform" rating in a research note on Thursday, February 6th. Finally, Bank of America raised their price target on Align Technology from $200.00 to $206.00 and gave the stock an "underperform" rating in a report on Friday, December 13th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Align Technology currently has an average rating of "Moderate Buy" and a consensus target price of $262.64.

Align Technology Stock Down 0.2 %

Shares of ALGN traded down $0.37 during mid-day trading on Tuesday, reaching $170.00. The company had a trading volume of 570,589 shares, compared to its average volume of 804,164. The stock has a 50 day moving average of $197.10 and a two-hundred day moving average of $215.77. The stock has a market capitalization of $12.51 billion, a P/E ratio of 30.30, a PEG ratio of 2.24 and a beta of 1.69. Align Technology, Inc. has a 52-week low of $158.13 and a 52-week high of $331.64.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. On average, sell-side analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.